Co-Diagnostics, Inc. (CODX) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 2.86M USD | Liabilities, Current |
| Cash and equivalents | 3.65M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current |
| Customer receivables | 52.06K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 841.67K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $2.86M | $3.65M | (m) | $52.06K | $841.67K | (m) |
| 2026-03-31 | (m) | $4.28M | $8.23M | (m) | $82.34K | $846.12K | (m) |
| 2025-12-31 | (m) | $3.54M | $11.88M | (m) | $190.38K | $992.40K | (m) |
| 2025-09-30 | (m) | $3.69M | $11.44M | (m) | $55.91K | $1.09M | (m) |
| 2025-06-30 | $13.57M | $3.71M | $11.12M | $2.25M | $210.97K | $1.08M | 3.66× |
| 2025-03-31 | $21.62M | $5.38M | $1.90M | $19.58M | $136.39K | $1.08M | 4.02× |
| 2024-12-31 | $29.88M | $7.32M | $2.94M | $26.81M | $132.57K | $1.07M | 4.08× |
| 2024-09-30 | $37.84M | $5.80M | $10.80M | $26.86M | $178.24K | $1.27M | 6.53× |
| 2024-06-30 | $45.43M | $5.31M | $13.86M | $31.02M | $551.50K | $1.46M | 8.56× |
| 2024-03-31 | $50.40M | $5.27M | $23.10M | $26.86M | $434.87K | $1.55M | 9.56× |
| 2023-12-31 | $58.85M | $5.75M | $14.92M | $43.63M | $303.93K | $1.66M | 10.24× |
| 2023-09-30 | $64.24M | $5.10M | $10.24M | $53.19M | $806.70K | $4.52M | 12.60× |
| 2023-06-30 | $70.24M | $5.12M | $13.83M | $55.31M | $1.10M | $4.69M | 13.73× |
| 2023-03-31 | $77.98M | $3.61M | $6.36M | $68.92M | $2.70M | $5.29M | 21.60× |
| 2022-12-31 | $84.72M | $3.87M | $22.97M | $58.29M | $3.45M | $5.31M | 21.87× |
| 2022-09-30 | $94.45M | $6.01M | $81.51M | $4.98M | $7.96M | $5.44M | 15.71× |
| 2022-06-30 | $108.26M | $6.72M | $86.05M | $9.95M | $12.26M | $4.71M | 16.12× |
| 2022-03-31 | (m) | $13.02M | $97.42M | (m) | $21.66M | $4.90M | (m) |
| 2021-12-31 | $110.70M | $12.60M | $88.61M | $1.26M | $20.84M | $2.00M | 8.79× |
| 2021-09-30 | $98.50M | $4.12M | $82.66M | $1.25M | $14.59M | $3.30M | 23.91× |
| 2021-06-30 | $85.14M | $4.73M | $70.27M | $2.11M | $12.76M | $4.12M | 18.00× |
| 2021-03-31 | $72.21M | $4.31M | $57.79M | $2.30M | $12.12M | $6.20M | 16.77× |
| 2020-12-31 | $59.45M | $4.51M | $42.98M | $4.34M | $12.14M | $8.00M | 13.18× |
| 2020-09-30 | $37.92M | $1.81M | $21.23M | $6.05M | $10.64M | $10.73M | 20.90× |
| 2020-06-30 | (m) | $2.98M | $18.55M | (m) | $5.35M | $10.11M | (m) |
| 2020-03-31 | (m) | $1.19M | $17.37M | (m) | $1.06M | $686.08K | (m) |
| 2019-12-31 | (m) | $328.07K | $893.14K | (m) | $131.38K | $197.17K | (m) |
| 2019-09-30 | (m) | $307.88K | $2.54M | (m) | $60.35K | $17.35K | (m) |
| 2019-06-30 | (m) | $312.08K | $3.86M | (m) | $62.98K | $8.23K | (m) |
| 2019-03-31 | (m) | $337.51K | $5.41M | (m) | $42.56K | $18.15K | (m) |
| 2018-12-31 | (m) | $2.35M | $950.24K | (m) | $13.42K | $18.15K | (m) |
| 2018-09-30 | (m) | $2.19M | $2.18M | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $290.57K | $1.53M | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $286.34K | $2.54M | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $628.26K | $3.53M | (m) | (m) | $9.07K | (m) |
| 2017-09-30 | (m) | $677.02K | $4.63M | (m) | (m) | $45.34K | (m) |
| 2017-06-30 | (m) | $4.67M | $116.77K | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | $496.45K | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $3.85M | $998.74K | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | $53.37K | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | $1.47K | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $33.80K | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |